You are here: Home » Current Affairs » Coronavirus » News
Britain moves closer to Covid-19 vaccine trials that infect volunteers
India gained more than a decade of life expectancy since 1990: Lancet
Business Standard

Pfizer confirms possible November coronavirus vaccine application

Safety review dictates the timeline, with the Food and Drug Administration requiring that at least half the people in the study be watched for side effects for two months

Topics
Coronavirus | Pfizer | Coronavirus Vaccine

Naomi Kresge | Bloomberg 



Vaccine
Pfizer and its German partner BioNTech SE are on track to potentially be the first to show the efficacy of a Covid-19 vaccine

Inc. said it could seek emergency-use authorization for its Covid-19 vaccine in the US by late November if the shot is shown to be effective in a large late-stage trial.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Sat, October 17 2020. 01:06 IST

RECOMMENDED FOR YOU